K. Kostikas (Ioannina, Greece), B. Alcazar Navarrete (Cájar, Spain)
Late Breaking Abstract - Blood Eosinophils as Predictor of Outcomes in hospitalized COPD Exacerbations: Results from a Prospective Study
K. Kostikas (IoanninaAthens, Greece), E. Papathanasiou (AthensIoanninaAthens, Greece), A. Papaioannou (AthensIoanninaAthens, Greece), K. Bartziokas (IoanninaAthens, Greece), I. Papanikolaou (CorfuAthensIoanninaAthens, Greece), E. Antonakis (CorfuAthensIoanninaAthens, Greece), I. Makou (CorfuAthensIoanninaAthens, Greece), G. Hillas (CAthensorfuAthensIoanninaAthens, Greece), T. Karampitsakos (CAthensorfuAthensIoanninaAthens, Greece), O. Papaioannou (CAthensorfuAthensIoanninaAthens, Greece), A. Dimakou (CAthensorfuAthensIoanninaAthens, Greece), G. Verykokou (AthensIoanninaAthens, Greece), V. Apollonatou (AthensIoanninaAthens, Greece), S. Papiris (AthensIoanninaAthens, Greece), P. Bakakos (Athens, Greece), S. Loukides (AthensIoanninaAthens, Greece)
|    |
Elevated baseline blood eosinophil count is related to greater lung function decline over 20-years of follow-up.
I. Mogensen (Uppsala, Sweden), C. Janson (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden)
| |
Eosinophil counts as a predictor of future COPD exacerbations in the DYNAGITO trial
P. Calverley (Liverpool, United Kingdom), C. Jenkins (Sydney, Australia), J. Wedzicha (London, United Kingdom), A. De La Hoz (Ingelheim am Rhein, Germany), F. Voß (Ingelheim am Rhein, Germany), K. Rabe (Grosshansdorf, Germany), A. Anzueto (San Antonio, United States of America)
|  |
The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma
J. Schmid (Aarhus, Denmark), B. Hviid-Vyff (Aarhus, Denmark), T. Skjold (Aarhus, Denmark), H. Hoffmann (Aarhus, Denmark)
| |
RELATIONSHIP BETWEEN BLOOD EOSINOPHILS AND EMPHYSEMA IN A COPD POPULATION
N. Toledo Pons (PALMA, Spain), T. Alonso Perez (MADRID, Spain), M. Passo Sanz (MADRID, Spain), J. Ancochea Bermudez (MADRID, Spain), J. Soriano Ortiz (MADRID, Spain), B. G. Cosío Piqueras (PALMA, Spain)
| |
Consistent effects of atopy and smoking on FeNO in American and European large population-based samples
T. Queirós Jacinto (Porto, Portugal), J. Fonseca (Porto, Portugal), B. Bake (Gothenburg, Sweden), K. Torén (Gothenburg, Sweden), A. Olin (Gothenburg, Sweden), K. Alving (Uppsala, Sweden)
| |
FENO Guided Therapy in Asthma: A Non-inferiority Study
T. Kulkarni (Kolkata, India), A. Mukherjee (Kolkata, India), B. Biswas (Kolkata, India), A. Ghosal (Kolkata, India), R. Dhar (Kolkata, India)
| |
Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
M. Kerkhof (Singapore, Singapore), J. Voorham (Singapore, Singapore), C. Cabrera (Mölndal, Sweden), P. Darken (Morristown, NJ, United States of America), P. Dorinsky (Durham, NC, United States of America), J. Kocks (Singapore, Singapore), M. Sadatsafavi (Vancouver, BC, Canada), D. Sin (Vancouver, BC, Canada), D. Price (Singapore, Singapore)
| |